<code id='B9951F5B70'></code><style id='B9951F5B70'></style>
    • <acronym id='B9951F5B70'></acronym>
      <center id='B9951F5B70'><center id='B9951F5B70'><tfoot id='B9951F5B70'></tfoot></center><abbr id='B9951F5B70'><dir id='B9951F5B70'><tfoot id='B9951F5B70'></tfoot><noframes id='B9951F5B70'>

    • <optgroup id='B9951F5B70'><strike id='B9951F5B70'><sup id='B9951F5B70'></sup></strike><code id='B9951F5B70'></code></optgroup>
        1. <b id='B9951F5B70'><label id='B9951F5B70'><select id='B9951F5B70'><dt id='B9951F5B70'><span id='B9951F5B70'></span></dt></select></label></b><u id='B9951F5B70'></u>
          <i id='B9951F5B70'><strike id='B9951F5B70'><tt id='B9951F5B70'><pre id='B9951F5B70'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:focus    Page View:66
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In